Quick Resolution of Serous Macular Detachment After HBO Therapy in an Atypical Toxoplasmic Retinochoroiditis
Murat KÜÇÜKEVCİLİOĞLU1, Önder AYYILDIZ1, Gökhan ÖZGE1, A. Hakan DURUKAN2, Cem ÖZGÖNÜL3, Seçkin AYKAŞ1
1M.D. GATA Medical Faculty, Department of Ophthalmology, Ankara/TURKEY 2M.D. Professor, GATA Medical Faculty, Department of Ophthalmology, Ankara/TURKEY 3M.D. Van Military Hospital, Ophthalmology Department, Van, Turkey
We herein report an atypical toxoplasmic retinochoroiditis case in which serous macular detachment (SMD) responded quickly to HBO therapy.
A 24-year-old male patient referred to our department complaining of decreased vision in his left eye. Fundoscopy revealed an old retinochoroidal
scar, and deep retinal whitening 2 disc diameters in size adjacent to the old scar with a large SMD exceeding the vascular arcades.
Though the antibodies were negative, the diagnosis of toxoplasmic retinochoroiditis was made. Since the main reason for decreased vision
was SMD, and ischeamic properties of the disease he was offered and then had 20 sessions of HBO therapy. Serous macular detachment was
completely resolved after 10 sessions of HBO therapy, and a small scar with full vision was observed at 1-month visit. Based on our current
experience HBO therapy may have a potential use in toxoplasmic retinochoroiditis with ischemic complications such as SMD, retinal vascular
occlusions, macular edema or choroidal neovascularizations.
Toxoplasma, retinochoroiditis, hyperbaric oxygen, serous macular detachment